GLP-1 & GIP analogs
Tirzepatide
- CAS
- 2023788-19-2
- MW
- 4813.5 g/mol
- Half-life
- ~5 days
A synthetic Tirzepatide preparation used in incretin-pathway and appetite-signalling research models.
NT$170VAT incl.
Batch TVL-2609-001 · 99%+
Ships from our mainland China warehouse, 3–7 business days to Taiwan.
Research use only. Not for human or animal consumption. Age and research-use verification required at checkout.
Description
A synthetic Tirzepatide preparation used in incretin-pathway and appetite-signalling research models.
GLP-1 and GIP receptor agonists and analogs are widely referenced in research on incretin signalling, insulin secretion, gastric emptying, and appetite regulation, commonly used in preclinical models of glucose homeostasis and metabolic pathways.
Storage & Handling
Store lyophilized (freeze-dried) peptide at -20°C, protected from light, until reconstitution. Once reconstituted with bacteriostatic or sterile water, store refrigerated at 2–8°C and use within the timeframe indicated by your reconstitution reference material. Avoid repeated freeze-thaw cycles. For laboratory research use only — not for human or animal consumption, diagnostic, therapeutic, or veterinary use.
Test Results
Every order ships with the Certificate of Analysis (COA) for that batch, so the label can be verified rather than taken on trust. The table below shows the current batch and purity for each size.
| Size | Batch | Purity |
|---|---|---|
| 5mg*10vials | TVL-2609-001 | 99%+ |
| 10mg*10vials | TVL-2609-002 | 99%+ |
| 15mg*10vials | TVL-2609-003 | 99%+ |
| 20mg*10vials | TVL-2609-004 | 99%+ |
| 30mg*10vials | TVL-2609-005 | 99%+ |
| 60mg*10vials | TVL-2609-006 | 99%+ |